Submicromolar paclitaxel induces apoptosis in human gastric cancer cells at early G1 phase

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3443-3449

  Lin, Heng Liang ^a,b   Chang, Yuh Fang ^a   Liu, Tsung Yun ^a,b   Wu, Chew Wun ^a,b   Chi, Chin Wen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cell cycle; Gastric cancer; Paclitaxel

Indexed keywords

BERBERINE; HYDROXYUREA; MIMOSINE; PACLITAXEL; STAUROSPORINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; METAPHASE; PRIORITY JOURNAL; STOMACH CANCER;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BERBERINE; CYCLIN E; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; HUMANS; MIMOSINE; PACLITAXEL; STAUROSPORINE; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031762622     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chabner BA: Paclitaxel Princ Pract Oncol 5: 1-10, 1991.
2. Rowinsky EK, Donehower RC: Paclitaxel: twenty years later, the story unfound. J Natl Cancer Inst 83: 1778-1781, 1991.
3. Slichenmyer WJ, Von Hoff DD: Paclitaxel: a new effective anticancer drug. Anticancer Drug 2: 519-530, 1991.
4. Rowinsky EK, Cazenave LA, Donehower RC: Paclitaxel: a novel investigational antimicrotubule agent. J Natl Cancer Inst. 82: 1247-1259, 1990.
5. Dustin P: Microtubule. Sci Am 243: 66-76, 1980.
6. Wilson L: Microtubules as drug receptor: pharmacological properties of microtubule protein. Ann N Y Acad Sci 253: 213-231, 1975.
7. Rowinsky EK, Donehower RC, Jonse RJ, Turker RW: Microtubule changes and cytotoxicity in leukemic cell lines treated with paclitaxel. Cancer Res 48: 4093-100, 1988.
8. Roberts JR, Allison DC, Donehower RC, Rowinsky EK: Development of polyploidization in paclitaxel-resistant human leukemia cell in vitro. Cancer Res 50: 710-716, 1990.
9. Rowinsky EK, Burke PJ, Karp JE, Tucker RW, Ettinfer DS, Donehwer RC: Phase I and pharmacodynamic study of paclitaxel in refractory adult acute leukemias. Cancer Res 49: 4640-4647, 1989.
10. De Brabander M, Geuens G, Nuysdens R, De Mey J: Paclitaxel induces the assembly of free microtubule in living cells and blocks the organizing capacity of the centrosome and kinetochores. Proc Natl Acad Sci USA 78: 5608-5612, 1981.
11. Milross CG, Mason KA, Hunter NR, Chung WK, Peter LJ, Milas L: Relationship of mitotic arrest and apoptosis to antitumor effect of Paclitaxel. J Natl Cancer Inst 88: 1308-1314, 1996.
12. Crossin KL, Carney DH: Microtubule stabilization by paclitaxel inhibits initiation of DNA synthesis by thrombin and by epidermal growth factor. Cell 27: 341-350, 1981.
13. Otto AM, De Asua LJ: Microtubule-disrupting agent can independently affect the prereplicative period and the entry into S phase stimulated by prostaglandin F2 and fibroblastic growth factor. J Cell Physiol 115: 15-22, 1983.
14. Keller HU, Zimmermann A: Shape changes and chemokinesis of Walker 256 carcinosarcoma cells in response to colchicine, vinblastin, nocodazole and paclitaxel. Invasion Metastasis 6: 33-43, 1986.
15. Rainey WE, Kramer RE, Mason JI, Shay JW: The effect of paclitaxel, a microtubule-stabilizing drug, on steroidogenic cells. J Cell Physiol 123: 17-24, 1985.
16. Stearns ME, Wang M: Paclitaxel blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res 52: 3776-3781, 1992.
17. Long BH, Fairchild CR: Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54: 4355-4361, 1994.
18. Eric KR, Ross CD: Paclitaxel (taxol). New Eng J Med 332: 1004-1014, 1995.
19. Torres KE, Gastillo G, Horwitz, SB: Induction of apoptosis by low concentrations of paclitaxel is not dependent on a G2/M block. Proc Am Assoc Cancer Res 38: 530, 1997.
20. Chang YF, Li LL, Wu CW, Liu WY, P'eng FK, Chi CW: Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18, 1996.
21. Jin LD, Meng CL, Han SH, Ding MJ, Chan TK, Shem KL: A study on production of monoclonal antibodies using SC-M1 cells as immunogen. J Med Sci 8: 17-28, 1987.
22. Yang IW, Chou CC, Yung BY: Dose-dependent effects of berberine on cell cycle pause and apoptosis in Balb/c 3T3 cells. Naunyn-Schmiedebergs Archi. Pharmacol 354: 102-108, 1996.
23. Lieu CH, Chang YN, Lai YK: Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. Biochem. Pharmacol 53: 1587-1596, 1997.
24. Akutsu M, Kano Y, Tsunoda S, Suzuki K, Yazawa Y, Miura Y: Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro. Eur J Cancer 31A: 2341-2346, 1995.
25. Kano Y, Akutsu M, Tsunoda S, Suzuki K, Yazawa Y: In vitro schedule-dependent interaction between paclitaxel and cisptatin in human carcinoma cell lines. Cancer Chemother Pharmacol 37: 525-530, 1996.
26. Kano Y, Akutsu M, Tsunoda S, Ando J, Matsu J, Suzuki K, Inoue Y, Adachi KI: Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro. Brit J Cancer 74: 704-710, 1996.
27. Vanhoefer U, Harstric A, Wilke H, Schleucher N, Walles H, Schroder J, Seeber S: Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro. Eur J Cancer 31A: 92-97, 1995.
28. Rowinsky E, Gibert MR, McGuire WP, Noe DA, Grochow LB, Forastiere AA, Ettinger DS, Lubejko BG, Clark B, Sartorius SE, Cornblath DR, Hendricks CB, Donehower RC: Sequences of paclitaxel and cisplatin: A phase I and pharmacologic study. J Clin Oncol 9: 1692-1703, 1991.
29. Gong J, Traganos F, Darzynkiewicz Z: Use of cyclin E restriction point to map cell arrest in G1 induced by n-butyrate, cycloheximide, staurosporine, lovastatin, mimosine and quercetin. J Oncol 4: 803-808, 1994.
30. cdc2 coincident with taxol-induced apoptosis. Cell Growth Diff. 5: 1041-1050, 1994
31. Kluck RM, Bossy-wetzel E, Green DR, Newmeyer DD: The release of cytochrome c from mitichondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
32. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
33. Ibrado AM, Hunang Y, Fang Guofu, Bhalla K: Bcl-xL overexpression inhibits paclitaxel-induced Yama protease activity and apoptosis. Cell Growth Diff 7: 1087-1094, 1996.
34. Tang C, Willingham MC, Reed JC, Miyashita T, Ray S, Ponnathpur V, Huang Y, Mahoney ME, Bullock G, Bhalla K: High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells. Leukemia 8: 1960-1969, 1994..
35. Haldar S, Basu A and Croce CM: bcl2 is the guardian of microtubule integrity. Cancer Res 57: 229-233, 1997.